StockData
Vertex Pharmaceuticals Inc logo

Vertex Pharmaceuticals Inc

VRTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026Score 15/3036% above fair value
$553.15−5.73 (-1.03%)

Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –

Vertex Pharmaceuticals Employee tax withholding by Quarter

Employee tax withholding — Shares withheld on equity vesting (M shares) (M)

QuarterlyAnnual

Vertex Pharmaceuticals Employee tax withholding: 0M in Q2 2026.

Latest, Q2 2026
0
Period ended Jun 30, 2026
Change on a year earlier
–
0 in Q2 2025
History
30 quarters
Since Q1 2019
Sources
25
Documents cited below

Where the Q2 2026 figure comes from

Calculated from reported figures: quarter = year-to-date − previous year-to-date (cash flow statement)

Source: Form 10-Q (filed 2026-08-04) ↗

Reported in Form 10-Q / 10-K Consolidated Statements of Stockholders' Equity.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedEmployee tax withholding — Shares withheld on equity vesting (M shares) (M)Year on yearSource
Q2 2026Jun 30, 20260–Form 10-Q (filed 2026-08-04) ↗
Q1 2026Mar 31, 20260.50-16.7%Form 10-Q (filed 2026-05-05) ↗
Q4 2025Dec 31, 2025-0.10–Form 10-K (filed 2026-02-13) ↗
Q3 2025Sep 30, 20250.200.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2025Jun 30, 20250-100.0%Form 10-Q (filed 2026-08-04) ↗
Q1 2025Mar 31, 20250.600.0%Form 10-Q (filed 2026-05-05) ↗
Q4 2024Dec 31, 20240–Form 10-K (filed 2026-02-13) ↗
Q3 2024Sep 30, 20240.20+100.0%Form 10-Q (filed 2025-11-04) ↗
Q2 2024Jun 30, 20240.10–Form 10-Q (filed 2025-08-05) ↗
Q1 2024Mar 31, 20240.600.0%Form 10-Q (filed 2025-05-06) ↗
Q4 2023Dec 31, 20230–Form 10-K (filed 2026-02-13) ↗
Q3 2023Sep 30, 20230.10-50.0%Form 10-Q (filed 2024-11-05) ↗
Q2 2023Jun 30, 20230–Form 10-Q (filed 2024-08-02) ↗
Q1 2023Mar 31, 20230.60+20.0%Form 10-Q (filed 2024-05-07) ↗
Q4 2022Dec 31, 20220–Form 10-K (filed 2025-02-13) ↗
Q3 2022Sep 30, 20220.20+100.0%Form 10-Q (filed 2023-11-07) ↗

Cite this data

StockData. (2026). Vertex Pharmaceuticals Employee tax withholding (M), quarterly Q1 2019–Q2 2026 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/sbc-tax-withhold-sh

See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.